ALCLOMETASONE Drug Patent Profile
✉ Email this page to a colleague
When do Alclometasone patents expire, and when can generic versions of Alclometasone launch?
Alclometasone is a drug marketed by Fougera Pharms, Glenmark Pharms Ltd, and Sun Pharma Canada. and is included in six NDAs.
The generic ingredient in ALCLOMETASONE is alclometasone dipropionate. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the alclometasone dipropionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Alclometasone
A generic version of ALCLOMETASONE was approved as alclometasone dipropionate by SUN PHARMA CANADA on July 29th, 2004.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ALCLOMETASONE?
- What are the global sales for ALCLOMETASONE?
- What is Average Wholesale Price for ALCLOMETASONE?
Summary for ALCLOMETASONE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 6 |
| Drug Prices: | Drug price information for ALCLOMETASONE |
| DailyMed Link: | ALCLOMETASONE at DailyMed |


